Media kits

The following media kits are made available to provide reporters with background information on the range of Medtronic diabetes therapies and the conditions they treat.

MiniMed™ 780G system media kit

MiniMed 780G system media kit

Information about the MiniMed 780G system which is the first system with meal detection technology* that provides automatic adjustments and corrections to sugar levels every 5 minutes§.

View kit

MiniMed™ 770G system media kit

MiniMed 770G system media kit

Information about the MiniMed 770G system which features smartphone connectivity and an expanded age indication down to the age of 2 years old.

View kit

InPen™ smart insulin pen

InPen smart insulin pen system

Information about the InPen smart insulin pen system.

View kit

MiniMed™ 670G system media kit

MiniMed 670G system media kit

Information about the MiniMed 670G system, the world’s first hybrid closed loop system for individuals with type 1 diabetes.

View kit

Guardian™ Connect continuous glucose monitoring (CGM) system media kit

Guardian Connect system media kit

Information about the Guardian Connect Continuous Glucose Monitoring (CGM) system, the first smart standalone CGM system to help people with diabetes using multiple daily injections (MDI) stay ahead of high and low glucose events.^

View kit

Diabetes management media kit

Diabetes management media kit

Information about Medtronic insulin pump therapy, continuous glucose monitoring and therapy management software.

View kit

*Taking a bolus 15 – 20 minutes before a meal helps to keep blood sugar levels under control after eating.

† Refers to auto correct, which provides bolus assistance. Can deliver all auto correction doses automatically without user interaction, feature can be turned on and off.

§ Refers to SmartGuard™ feature. Individual results may vary.
‡ Smart insulin pens connect to a mobile app to provide dosing calculations, reminders and CGM system integration.
^ Smart CGM predicts future high and low sensor glucose events up to 60 minutes in advance and provides access to Sugar.IQ insights that can inform users of clinically relevant glucose patterns.